Ovarian Cancer Clinical Trials

Ovarian cancer is known as the silent killer. Every 48 hours in New Zealand one women will lose her life to this disease. Of the five gynaecological cancers, ovarian cancer has the highest death rate. By the time 85% of women are diagnosed, the disease is in the later stage limiting treatment options.

K9MD is delighted to now have three quality medical detection dogs devoted to training for the early non-invasive detection of Ovarian Cancer. Both K9MD Hunter (German shepherd), K9MD Hogan (Golden Labrador) and K9MD Skye(Black Labrador) have shown their quality genetic heritage and have been imprinted on the odour released for Ovarian cancer. Both K9 Hogan and K9 Hunter have competed Proof-Of-Concept validations and their results can be found on the Cancer Research Update page.

We have received ethics approval and are recruiting nurses throughout New Zealand to collect patient urine samples. 

Hunter, Hogan and Skye will become  top medical detection dogs and truly women’s best friend.

We are delighted to be working with a specialist team for Ovarian cancer from the awesome team at Oxford Women's Health. 

The K9MD Team believe that all New Zealand women deserve the right to have the option of an early, non-invasive test for this horrendous disease.